NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/11/2024
Back to search
Official data from USPTO
WUXIUP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
06/11/2024
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
03/20/2023
Registration date
06/11/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/11/2024
Last transaction
06/11/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2018-12-00
First use in commerce
2018-12-00
Drawing code
4
Owner type
99
Owner location
DUNDALK, CO LOUTH, IE
Examiner
GEARHART, JESSICA
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
WUXI BIOLOGICS IRELAND LIMITED
Representatives
Michael T. Smith BIRCH STEWART KOLASCH & BIRCH, LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Product development for others; pharmaceutical drug development services; scientific research and development; pharmaceutical research; research and development of new products; Consulting services in the field of pharmaceutical technology development; biochemical research and analysis; research services for biomedical science; pharmaceutical preparations and medicines development; research and development of antibodies
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/11/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/07/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/07/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/22/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/22/2024
IUAF
USE AMENDMENT FILED
01/30/2024
EISU
TEAS STATEMENT OF USE RECEIVED
01/30/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/16/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/21/2023
PUBO
PUBLISHED FOR OPPOSITION
11/21/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/16/2023
DOCK
ASSIGNED TO EXAMINER
10/03/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/11/2023
NWAP
NEW APPLICATION ENTERED
03/23/2023
Continuous trademark protection
Get notified about every new filing that threatens WUXIUP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.